Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the multiple outcomes of Raloxifene Evaluation trial11Eli Lilly and Company (Indianapolis, IN) sponsored the Multiple Outcomes of Raloxifene Evaluation (MORE) trial.-Reference-Cited by-同舟云学术

Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the multiple outcomes of Raloxifene Evaluation trial11Eli Lilly and Company (Indianapolis, IN) sponsored the Multiple Outcomes of Raloxifene Evaluation (MORE) trial.

Published:2003-09 Issue:3 Volume:33 Page:293-300
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Kanis John A,Johnell Olof,Black Dennis M,Downs Robert W,Sarkar Somnath,Fuerst Thomas,Secrest Roberta J,Pavo Imre

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference31 articles.

1. Involutional osteoporosis;Riggs;N Engl J Med,1986

2. The burden of osteoporosis;Kanis;J Endocrinol Invest,1999

3. Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis;Genant;Osteoporos Int,1999

4. Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group;Ettinger;J Bone Miner Res,1992

5. The association of radiographically detected vertebral fractures with back pain and function;Nevitt;Ann Intern Med,1998

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized controlled trial of the effect of raloxifene plus cholecalciferol versus cholecalciferol alone on bone mineral density in postmenopausal women with osteopenia;JBMR Plus;2024-05-30

2. Diagnosis and Management of Osteoporosis: A Comprehensive Review of Guidelines;Obstetrical & Gynecological Survey;2023-11

3. Simultaneous estimation of raloxifene and cladrin by HPLC: application to metabolic stability studies in different species;Bioanalysis;2023-06

4. Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials;BMJ;2023-05-02

5. A randomized, open-label, single-dose, two-way crossover study to assess the pharmacokinetics between two tablets of fixed-dose combination formulation with raloxifene and cholecalciferol and concomitant administration of each agents in healthy male volunteers;Translational and Clinical Pharmacology;2022